header
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 - Next
Half-century-old TB drugs get a facelift in new cocktails
12/01/2010 | STU HUTSON | Nature Medicine
The first-line regime of tuberculosis drugs has remained virtually unchanged for a half century. But instead of improving on these medications, some r
WHO says deadly TB scourge preventable
11/11/2010 | STEPHANIE NEBEHAY | Reuters
GENEVA - Health authorities worldwide must do more to combat tuberculosis, which killed an estimated 1.7 million people last year, mainly adults in th
David Brennan of AstraZeneca says public sector crucial to drug research
10/11/2010 | BY JULIA KOLLEWE | The Guardian
AstraZeneca’s chief executive will this week urge ministers to work with the pharmaceutical industry to share the risks and costs in developing
Regulatory Conference Shows The Way Forward From Lessons Learnt In The Past
8/19/2010 | SHOBHA SHUKLA | Citizen News Service
The 4th Open Forum Conference was held in Addis Ababa, Ethiopia on 18th and 19th August to address key issues in developing new drugs for tuberculosis
Anti-TB compounds could fight neglected diseases
7/07/2010 | STEPHANIE NEBEHAY | Reuters
Compounds being developed against tuberculosis also show promise against deadly tropical diseases threatening millions of people, two not-for-profits
TB TREATED LIKE OTHER RESPIRATORY DISEASES IN FUTURE
6/03/2010 | South African Press Association
Better drugs and understanding should see tuberculosis treated like any other respiratory disease in future, the TB Alliance said in Durban on Thursda
Drug-resistant TB risk demands push for new drugs
5/18/2010 | KATE KELLAND | Reuters
LONDON  - Multi-drug resistant strains of tuberculosis (TB) could become dominant forms of the disease in the next few decades, adding heavy fina
China fights growing problem of tuberculosis
1/06/2010 | TAN EE LYN | Reuters
GUANGZHOU, China, Jan 6 (Reuters) - China, saddled with the world's second largest tuberculosis burden after India, is fighting an uphill battle again
Hopes of new drugs, vaccines for tuberculosis
12/07/2009 | TAN EE LYN | Reuters
CANCUN, Mexico (Reuters) - In Uganda, health experts are getting laboratories ready and preparing villagers in two districts for a large clinical tria
New development in TB treatment
6/18/2009 | ANSO THOM | Health-E
Pharmaceutical giant Tibotec and the non-profit Global Alliance for TB Drug Development (TB Alliance) have teamed up to expedite the development of
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 - Next

Media Support Section
click here

For additional information please email:

newsmedia@tballiance.org

New Study: Drivers of TB Regimen Change in High-Burden Countries
Stakeholders cite key actions critical to maximize uptake and impact of new TB regimen introductions
5/09/2011
The Private Market for Tuberculosis Drugs: Big and Messy, but a Necessary Partner in Stopping the TB Epidemic
The private TB drug market, which has irregular practices that could be driving treatment failures and the emergence of drug-resistant tuberculosis, is now shown to be as large as the public market.
5/04/2011
Combating Drug-Resistant Tuberculosis
4/07/2011
Celebrating World TB Day 2011
4/02/2011
WTBD Community Engagement 2011: TB Roadblock
Aurum Institute, Parktown, South Africa
4/01/2011
click to view all items